Ohtake N

No ORCID on file · 3 papers in corpus · active 2013-2024

Study types

  • article 2

Condition tags

  • endometriosis 2
2024
BMC cancer ·doi:10.1186/s12885-024-12827-0

BackgroundEndometrial cancer is the most common gynecological malignancy; however, there is no useful blood diagnostic biomarker. This study aimed to determine the utility of tissue factor pathway inhibitor 2 (TFPI2), a biomarker of ovarian…

article 2016
PloS one ·doi:10.1371/journal.pone.0165609

BACKGROUND: There is currently no reliable serum biomarker for ovarian clear cell carcinoma (CCC), a highly lethal histological subtype of epithelial ovarian cancer (EOC). Previously, using a proteome-based approach, we identified tissue fa…

article 2013
Journal of proteome research ·doi:10.1021/pr400282j

Of all of the epithelial ovarian cancers (EOC), clear cell adenocarcinoma (CCA) has the worst clinical prognosis. Furthermore, the conventional EOC biomarker CA125 is more often negative in CCA than in other subtypes of EOC. This study soug…